Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GTHP |
---|---|---|
09:48 ET | 110 | 0.2 |
10:32 ET | 300 | 0.215 |
02:42 ET | 1870 | 0.203792 |
03:54 ET | 4700 | 0.205 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Guided Therapeutics Inc | 7.7M | -1.6x | --- |
Healthtech Solutions Inc | 7.1M | -1.0x | --- |
GlucoTrack Inc | 8.9M | -1.4x | --- |
SeqLL Inc | 6.4M | -1.2x | --- |
Aethlon Medical Inc | 7.2M | -0.5x | --- |
Ra Medical Systems Inc | 5.6M | 0.0x | --- |
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on the development of medical devices. The Company develops prototypes and conducts limited clinical studies using its biophotonic technology for the detection of esophageal cancer. Its primary focus is selling and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide an alternative to conventional tests for cervical cancer screening and detection. It is focused on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage for various traditional screening.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.7M |
---|---|
Revenue (TTM) | $30.0K |
Shares Outstanding | 51.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.63 |
EPS | $-0.13 |
Book Value | $-0.06 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 255.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14,023.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.